icad inc. (NASDAQ:ICAD) issued its quarterly earnings results on Tuesday. The technology company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.03, reports. icad inc. had a negative return on equity of 38.00% and a negative net margin of 29.61%.

Shares of icad inc. (ICAD) traded down 3.392% during midday trading on Tuesday, reaching $3.845. The company’s stock had a trading volume of 14,295 shares. The stock’s 50-day moving average price is $4.04 and its 200-day moving average price is $4.34. The company’s market cap is $62.96 million. icad inc. has a 12-month low of $2.82 and a 12-month high of $6.49.

WARNING: “icad inc. (NASDAQ:ICAD) Issues Quarterly Earnings Results” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/08/icad-inc-nasdaqicad-issues-quarterly-earnings-results.html.

Separately, Laidlaw reissued a “buy” rating and issued a $11.00 price target on shares of icad inc. in a report on Tuesday, July 25th.

icad inc. Company Profile

iCAD, Inc is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy).

Earnings History for icad inc. (NASDAQ:ICAD)

Receive News & Ratings for icad inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for icad inc. and related companies with MarketBeat.com's FREE daily email newsletter.